These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7769868

  • 1. [Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Cortés E, Ribera E, Cucurull E, de Otero J, Ocaña I, Pahissa A.
    Med Clin (Barc); 1995 Apr 22; 104(15):578-80. PubMed ID: 7769868
    [Abstract] [Full Text] [Related]

  • 2. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J, Rivero A, Márquez M.
    An Med Interna; 2000 Oct 22; 17(10):562-3. PubMed ID: 11109659
    [No Abstract] [Full Text] [Related]

  • 3. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
    Gasser RA, Magill AJ, Oster CN, Franke ED, Grögl M, Berman JD.
    Clin Infect Dis; 1994 Jan 22; 18(1):83-90. PubMed ID: 7519887
    [Abstract] [Full Text] [Related]

  • 4. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
    Delgado J, Macías J, Pineda JA, Corzo JE, González-Moreno MP, de la Rosa R, Sánchez-Quijano A, Leal M, Lissen E.
    Am J Trop Med Hyg; 1999 Nov 22; 61(5):766-9. PubMed ID: 10586909
    [Abstract] [Full Text] [Related]

  • 5. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME, Laguna F, González Lahoz J.
    An Med Interna; 2000 Jan 22; 17(1):54. PubMed ID: 10730416
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.
    Hailu W, Weldegebreal T, Hurissa Z, Tafes H, Omollo R, Yifru S, Balasegaram M, Hailu A.
    Trans R Soc Trop Med Hyg; 2010 Nov 22; 104(11):706-12. PubMed ID: 20870258
    [Abstract] [Full Text] [Related]

  • 9. Meglumine antimoniate-induced pancreatitis.
    Torrús D, Massa B, Boix V, Portilla J, Pérez-Mateo M.
    Am J Gastroenterol; 1996 Apr 22; 91(4):820-1. PubMed ID: 8677970
    [No Abstract] [Full Text] [Related]

  • 10. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Stecca C.
    Clin Infect Dis; 1993 May 22; 16(5):730-1. PubMed ID: 8507769
    [No Abstract] [Full Text] [Related]

  • 11. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate.
    McBride MO, Linney M, Davidson RN, Weber JN.
    Clin Infect Dis; 1995 Sep 22; 21(3):710. PubMed ID: 8527590
    [No Abstract] [Full Text] [Related]

  • 12. [Pancreatitis during treatment of leishmaniasis with n-methylglucamine antimoniate in a subject infected with HIV].
    Trinchieri V, Ferone U, Monacelli M, Isceri L, Proietti F, Sorice F.
    Riv Eur Sci Med Farmacol; 1996 Sep 22; 18(2):49-51. PubMed ID: 9213843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N, Kara C, Bakirtaç A, Teziç T.
    Pediatr Infect Dis J; 2001 Apr 22; 20(4):455-7. PubMed ID: 11332679
    [Abstract] [Full Text] [Related]

  • 15. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
    Ribera E, Ocaña I, de Otero J, Cortes E, Gasser I, Pahissa A.
    Am J Med; 1996 May 22; 100(5):496-501. PubMed ID: 8644760
    [Abstract] [Full Text] [Related]

  • 16. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.
    Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, Seaman J, Davidson RN.
    Trans R Soc Trop Med Hyg; 2001 May 22; 95(6):668-72. PubMed ID: 11816442
    [Abstract] [Full Text] [Related]

  • 17. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M, Brunet P, Bernard JC, Dussol B, Rodor F, Jouglard J, Berland Y, Sahel J.
    Gastroenterol Clin Biol; 1994 May 22; 18(1):90-2. PubMed ID: 8187998
    [No Abstract] [Full Text] [Related]

  • 18. Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
    Shahian M, Alborzi A.
    Med Sci Monit; 2009 Jun 22; 15(6):CR290-3. PubMed ID: 19478699
    [Abstract] [Full Text] [Related]

  • 19. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
    Bermúdez H, Rojas E, Garcia L, Desjeux P, Dujardin JC, Boelaert M, Chappuis F.
    Ann Trop Med Parasitol; 2006 Oct 22; 100(7):591-600. PubMed ID: 16989685
    [Abstract] [Full Text] [Related]

  • 20. Treatment of cutaneous leishmaniasis in travelers 2009.
    Blum JA, Hatz CF.
    J Travel Med; 2009 Oct 22; 16(2):123-31. PubMed ID: 19335813
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.